These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11747276)

  • 81. [Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].
    Broll R; Lembcke K; Stock C; Zingler M; Duchrow M; Schimmelpenning H; Strik M; Muller G; Kujath P; Bruch HP
    Langenbecks Arch Chir; 1996; 381(1):51-8. PubMed ID: 8717176
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease.
    Thybusch-Bernhardt A; Klomp HJ; Maas T; Kremer B; Juhl H
    Eur J Surg Oncol; 1999 Oct; 25(5):498-502. PubMed ID: 10527598
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
    Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma.
    Cote RJ; Beattie EJ; Chaiwun B; Shi SR; Harvey J; Chen SC; Sherrod AE; Groshen S; Taylor CR
    Ann Surg; 1995 Oct; 222(4):415-23; discussion 423-5. PubMed ID: 7574923
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.
    Solomayer EF; Diel IJ; Meyberg GC; Gollan C; Bode S; Wallwiener D; Bastert G
    Breast Cancer Res Treat; 1998 May; 49(2):145-54. PubMed ID: 9696397
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value].
    Ditsch N; Funke I; Mayer B; Untch M
    MMW Fortschr Med; 2002 Oct; 144(41):37-9. PubMed ID: 12474359
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
    Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
    Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Significance of occult neoplastic cells on tumor metastasis: a case report of gastric cancer.
    Sato S; Mukai M
    Diagn Pathol; 2010 Feb; 5():14. PubMed ID: 20178643
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Image analysis systems for the detection of disseminated breast cancer cells on bone-marrow cytospins.
    Becker S; Becker-Pergola G; Fehm T; Emig R; Wallwiener D; Solomayer EF
    J Clin Lab Anal; 2005; 19(3):115-9. PubMed ID: 15900568
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients.
    Braun S; Harbeck N
    Breast Cancer Res; 2001; 3(5):285-8. PubMed ID: 11597315
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
    Diel IJ; Solomayer EF; Bastert G
    Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Importance of occult metastatic cells in the treatment of patients with breast and gastrointestinal cancers].
    Braun S; Auer M; Rosenberg R
    Acta Med Austriaca Suppl; 2002; 59():18-26. PubMed ID: 12506756
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.
    Braun S; Rosenberg R; Thorban S; Harbeck N
    Semin Surg Oncol; 2001 Jun; 20(4):334-46. PubMed ID: 11747276
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients.
    Braun S; Pantel K
    Oncologist; 2001; 6(2):125-32. PubMed ID: 11306724
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Molecular markers of metastasis in breast cancer: current understanding and prospects for novel diagnosis and prevention.
    Braun S; Harbeck N
    Expert Rev Mol Med; 2001 Sep; 3(22):1-14. PubMed ID: 14585146
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.